Stebėti
Theodoros Soldatos
Theodoros Soldatos
Nežinomas ryšys
Patvirtintas el. paštas molecularhealth.com
Pavadinimas
Cituota
Cituota
Metai
Using graph theory to analyze biological networks
GA Pavlopoulos, M Secrier, CN Moschopoulos, TG Soldatos, S Kossida, ...
BioData mining 4, 1-27, 2011
9762011
Src activation by β-adrenoreceptors is a key switch for tumour metastasis
GN Armaiz-Pena, JK Allen, A Cruz, RL Stone, AM Nick, YG Lin, LY Han, ...
Nature Communications 4, 1403, 2013
2382013
Arena3D: visualization of biological networks in 3D
GA Pavlopoulos, SI O'Donoghue, VP Satagopam, TG Soldatos, E Pafilis, ...
BMC systems biology 2, 1-7, 2008
1412008
A reference guide for tree analysis and visualization
GA Pavlopoulos, TG Soldatos, A Barbosa-Silva, R Schneider
BioData mining 3, 1-24, 2010
1282010
Association between serotonin syndrome and second‐generation antipsychotics via pharmacological target‐adverse event analysis
R Racz, TG Soldatos, D Jackson, K Burkhart
Clinical and translational science 11 (3), 322-329, 2018
602018
Laitor-literature assistant for identification of terms co-occurrences and relationships
A Barbosa-Silva, TG Soldatos, ILF Magalhães, GA Pavlopoulos, ...
BMC bioinformatics 11, 1-10, 2010
472010
Radioimmunotherapy in non-Hodgkin’s lymphoma: retrospective adverse event profiling of Zevalin and Bexxar
C Sachpekidis, DB Jackson, TG Soldatos
Pharmaceuticals 12 (4), 141, 2019
392019
How to learn about gene function: text-mining or ontologies?
TG Soldatos, N Perdigão, NP Brown, KS Sabir, SI O’Donoghue
Methods 74, 3-15, 2015
322015
Martini: using literature keywords to compare gene sets
TG Soldatos, SI O'Donoghue, VP Satagopam, LJ Jensen, NP Brown, ...
Nucleic acids research 38 (1), 26-38, 2010
312010
Target adverse event profiles for predictive safety in the postmarket setting
P Schotland, R Racz, DB Jackson, TG Soldatos, R Levin, DG Strauss, ...
Clinical Pharmacology & Therapeutics 109 (5), 1232-1243, 2021
282021
Retrospective side effect profiling of the metastatic melanoma combination therapy ipilimumab-nivolumab using adverse event data
TG Soldatos, A Dimitrakopoulou-Strauss, L Larribere, JC Hassel, ...
Diagnostics 8 (4), 76, 2018
282018
Biggest challenges in bioinformatics
JC Fuller, P Khoueiry, H Dinkel, K Forslund, A Stamatakis, J Barry, A Budd, ...
EMBO reports 14 (4), 302-304, 2013
252013
Precision oncology—The quest for evidence
TG Soldatos, S Kaduthanam, DB Jackson
Journal of Personalized Medicine 9 (3), 43, 2019
222019
Retrospective toxicological profiling of radium-223 dichloride for the treatment of bone metastases in prostate cancer using adverse event data
TG Soldatos, I Iakovou, C Sachpekidis
Medicina 55 (5), 149, 2019
202019
In Silico Profiling of Clinical Phenotypes for Human Targets Using Adverse Event Data
TG Soldatos, G Taglang, DB Jackson
High-throughput 7 (4), 37, 2018
172018
Advancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports
TG Soldatos, S Kim, S Schmidt, LJ Lesko, DB Jackson
CPT: Pharmacometrics & Systems Pharmacology 11 (5), 540-555, 2022
162022
Examining socioeconomic and computational aspects of vaccine pharmacovigilance
V Soldatou, A Soldatos, T Soldatos
BioMed Research International 2019 (1), 6576483, 2019
122019
Systems and methods for identifying unknown drug targets via adverse event data
D Jackson, T Soldatos, G Taglang, A Zien, S Brock
US Patent 9,218,457, 2015
122015
Adverse event circumstances and the case of drug interactions
TG Soldatos, DB Jackson
Healthcare 7 (1), 45, 2019
112019
Systems and methods for de-risking patient treatment
D Jackson, T Soldatos, G Taglang, A Zien, S Brock
US Patent App. 13/446,820, 2013
112013
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20